Vivani Medical, Inc. (NASDAQ:VANI – Get Free Report) saw a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 589,100 shares, a decline of 32.4% from the March 31st total of 871,100 shares. Approximately 2.0% of the shares of the company are sold short. Based on an average daily trading volume, of 3,010,000 shares, the short-interest ratio is presently 0.2 days.
Vivani Medical Stock Down 3.8 %
VANI opened at $1.63 on Monday. The firm has a market cap of $89.62 million, a price-to-earnings ratio of -3.26 and a beta of 3.26. Vivani Medical has a 52 week low of $0.84 and a 52 week high of $7.80. The business’s 50 day moving average is $1.93 and its two-hundred day moving average is $1.33.
Vivani Medical (NASDAQ:VANI – Get Free Report) last released its quarterly earnings results on Tuesday, March 26th. The company reported ($0.12) EPS for the quarter.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Five stocks we like better than Vivani Medical
- Do ETFs Pay Dividends? What You Need to Know
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 4/22 – 4/26
- How to Find Undervalued Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
